Sign in to view content

Safety and Efficacy of Intravitreal Optogenetic Gene Therapy for Advanced Retinitis Pigmentosa

Sai H Chavala, MD

Video
Published 2021

Related

BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Michael A. Singer, MD
Updates from the Field
2024
Stem Cell Therapy
Mark S. Humayun, MD, PhD
Updates from the Field
2017
Safety and Activity of a Single, Intravitreal Injection of Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa (RP)
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2018

Category: Hereditary Retinal Disease & Genetics

See more